Rosen Law Firm Announces Class Action Lawsuit on Behalf of Inspire Medical Systems, Inc. Shareholders

NEW YORK, Jan. 01, 2024 (GLOBE NEWSWIRE) — Renowned global investor rights law firm Rosen Law Firm has put forth an announcement regarding the initiation of a class action lawsuit. This legal action is on behalf of stockholders who purchased the common stock of Inspire Medical Systems, Inc., trading under the ticker INSP, between the dates of May 3, 2023, and November 7, 2023, inclusive. The lawsuit has been filed to address concerns over potential securities laws violations by Inspire Medical Systems, Inc.

Understanding the Allegations

The class action claims allege that Inspire Medical Systems may have released misleading financial information to investors and failed to disclose material information in a timely fashion, actions that potentially could have caused artificial inflation in the company's stock price.

Inspire Medical Systems at a Glance

Inspire Medical Systems, Inc., represented by the stock ticker INSP, is a medical technology enterprise based in Golden Valley, Minnesota. The company's primary focus is on the innovation and commercialization of minimally invasive solutions for individuals suffering from obstructive sleep apnea (OSA) and has a presence in the United States and Europe.

Legal Recourse for Shareholders

The Rosen Law Firm is advising all shareholders who have incurred financial losses during the specified period and held shares of INSP to seek legal counsel. The call for securing representation comes ahead of an important deadline pertaining to the class action lawsuit. With the legal expertise of the Rosen Law Firm, affected investors can aim to recoup their financial losses and hold Inspire Medical Systems accountable for any alleged misrepresentations or omissions.

RosenLawFirm, ClassAction, INSP